Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
INFINIUM
INFINIUM

Infinium Pharmachem Ltd.

NSE: INFINIUM
SME
Sector: Healthcare
Industry: Pharmaceuticals
219.50+9.5 (+4.55%)
7 Aug, 12:00 AM

Stock Scores

Quality Score

92.1 / 100

Value Score

70.7 / 100

Price Momentum Score

37.8 / 100

QVM Score

83.2 / 100

Key Metrics

Market Cap
305.46
P/E (TTM)
25.14
P/B
2.52
P/S (TTM)
1.61
EV/EBITDA
13.84
CAPE (5Y)
31.14
ROE (TTM)
10.54
ROCE (TTM)
10.95
ROA (TTM)
6.51
Avg 3Y ROE
16.00
Earnings 3Y CAGR
-5.81
Sales 3Y CAGR
18.41
Sales 5Y CAGR
21.87
Debt/Equity
0.19
Consensus TP
-
Strong Buy %
-
Promoter Holding
64.91
Pledged %
0.00

Share Price

Track Infinium Pharmachem Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: 5.28 %
Low
202.0
High
220.0
1 Month returns: 3.59 %
Low
202.0
High
220.0
1 Year returns: -18.66 %
Low
189.4
High
276.0
3 Year CAGR: -2.38 %
Low
178.1
High
392.5
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Infinium Pharmachem Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Infinium Pharmachem Ltd. Shareholding Pattern

Quarterly breakdown of Infinium Pharmachem Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Infinium Pharmachem Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Infinium Pharmachem Ltd.?
The current share price of Infinium Pharmachem Ltd. is ₹ 219.50 as of 7 Aug 2026.
What is the market capitalisation of Infinium Pharmachem Ltd.?
The market capitalisation of Infinium Pharmachem Ltd. stands at ₹ 305.46 Cr.
What is the PE ratio of Infinium Pharmachem Ltd.?
The Price-to-Earnings (PE) ratio of Infinium Pharmachem Ltd. is 25.14 as of the latest trailing twelve months data.
What is the ROE and ROCE of Infinium Pharmachem Ltd.?
Infinium Pharmachem Ltd. has a Return on Equity (ROE) of 10.54% and a Return on Capital Employed (ROCE) of 10.95% as per the latest financial reports.
What is the 52-week high and low of Infinium Pharmachem Ltd.?
The 52-week high of Infinium Pharmachem Ltd. is - and the 52-week low is -.
What is the dividend yield of Infinium Pharmachem Ltd.?
The dividend yield of Infinium Pharmachem Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Infinium Pharmachem Ltd.?
Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 34.74% of Infinium Pharmachem Ltd. shares.
What sector does Infinium Pharmachem Ltd. belong to?
Infinium Pharmachem Ltd. operates in the Healthcare sector.
What is the beta of Infinium Pharmachem Ltd.?
The beta of Infinium Pharmachem Ltd. is 0.35, indicating its price volatility relative to the broader market. Over the past 1 year, Infinium Pharmachem Ltd. has delivered an absolute return of -23.29%.
What is the RSI of Infinium Pharmachem Ltd.?
The 14-day Relative Strength Index (RSI) of Infinium Pharmachem Ltd. is 61.45, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.